Treatment of malignant pleural mesothelioma (MPM) is a challenge as the incidence is expected to increase in the next following decades and the prognosis remains poor. We present a case introducing different aspects in the treatment of MPM. We highlight the management of pleural effusion and ...
Stage 4 mesothelioma is the most advanced stage of this asbestos-related cancer. In this late stage, the mesothelioma cells have spread to distant body parts. Extensive tumor spread makes it difficult to treat. Surgery cannot remove this end stage of mesothelioma because mesothelioma cells and resu...
Which therapies will be used to treat biphasic mesothelioma depends on the ratio of epithelioid to sarcomatoid cells, as well as where the cancer has developed, how far it has spread, and the age and overall health of the patient. A case study published in the June 2023 edition of the Int...
for the local treatment of malignant mesothelioma (Koren et al., 1996) and afterward, different clinical trials with Hyp-PDT applied to various skin tumors have been published to date. Moreover, several compounds were isolated from plants and tested for their potential antitumor action triggered by...
Ranitidine is a pharmaceutical drug that is categorized as a histamine antagonist, also called an H2 blocker, that has popularly been used to treat acid reflux. However, this medication had recently raised controversies when the Food and Drug Administration (FDA) announced a product...
Those who worked directly with asbestos containing products, such as installers, demolition workers and do-it-yourselfers have been unaware of exposure to harmful asbestos fibers and now could be at risk for developing mesothelioma, an asbestos-related disease. Equally at risk were those who worked...
"Cells with cancer-causing mutations accumulate naturally as we age, but they are normally inactive. We've demonstrated that air pollution wakes these cells up in the lungs, encouraging them to grow and potentially form tumors. "The mechanism we've identified could ultimately help us to find be...
How do I treat……a patient with malignant pleural mesothelioma?Malignant mesothelioma is rare and poses some unique challenges. The practising oncologist is oftendoi:10.1097/01.OTU.0000411000.57172.a6KrugLee MOncology Times Uk
The present invention relates to a therapeutic method and a diagnostic method using an antibody that binds to a ganglioside GM2 antigen, and a therapeutic agent and a diagnostic agent comprising as an active ingredient an antibody that binds to a ganglioside GM2 antigen.矢野 聖二...
Frequent NF2 Inactivation in Mesothelioma: How Can We Treat Mesothelioma with Targeted Therapies for Molecular Aberrations?The NF2 gene was initially identified as a causative gene for neurofibromatosis type 2 cancer syndrome. Soon thereafter, NF2 was shown to be frequently mutated in malignant ...